DUBLIN, Oct. 21, 2021 /PRNewswire/ -- Medtronic plc
(NYSE:MDT), a global leader in healthcare technology, today
announced Austin L. Chiang, M.D.,
M.P.H., assistant professor of medicine at Sidney Kimmel Medical
College, chief medical social media officer of Jefferson Health and
director of the Endoscopic Bariatric Program at Thomas Jefferson University Hospital, has joined
Medtronic as Chief Medical Officer (CMO) of the Gastrointestinal
(GI) business at Medtronic.
In this role, Dr. Chiang will provide medical expertise and
strategic guidance on evidence development, clinical communications
and publications, and training and support needs. Additionally, he
will provide oversight to ensure patient safety throughout product
lifecycle, including the product development processes, risk
management, clinical trials, and safety surveillance. Dr. Chiang is
one of the few triple board-certified advanced endoscopy-trained
physicians in the world. His certifications include Internal
Medicine and Gastroenterology by the American Board of Internal
Medicine, and in Obesity Medicine by the American Board of Obesity
Medicine.
"As healthcare continues to evolve at such a rapid pace, we are
excited to add a clinician of Dr. Chiang's caliber to our
leadership team," said Giovanni Di
Napoli, president of the Gastrointestinal business, which is
part of the Medical Surgical Portfolio at Medtronic. "Dr. Chiang's
approach to medicine and educating healthcare providers and
patients is on the leading edge of healthcare innovation. His
forward thinking and desire to personalize medicine for patients
and providers will help Medtronic to continue evolving and serving
the ever-changing healthcare community."
"I am thrilled to be joining Medtronic at such an innovative
time in healthcare and especially in the gastrointestinal space,
helping to deliver on what is a promising future for those in need
of innovative GI care around the world," said Dr. Chiang. "I look
forward to joining a world-renowned team of brilliant engineers and
leading clinical experts that produce life-saving devices. I
anticipate collaborating with our Medtronic team across the globe
to produce solutions that best serve patients and increase quality
of care for all."
In addition to serving as Chief Medical Officer for the
Medtronic GI business, Dr. Chiang will continue to practice
clinically at Jefferson Health. "This is a great step in Dr.
Chiang's career as a Jefferson faculty member, and as one of the
nation's leading science advocates," said Stephen K. Klasko, M.D., MBA, president of
Thomas Jefferson University and CEO of
Jefferson Health. "This new role allows him to marry clinical care
and device innovation, and to use technology as the foundation for
the revolution in putting people first in health care
delivery."
A nationally recognized gastroenterologist and advanced
endoscopist, Dr. Chiang is passionate about empowering patients
with accurate medical information online. He serves on the board of
the Association for Bariatric Endoscopy (ABE) and is a committee
member for the American College of Gastroenterology (ACG) and the
American Society for Gastrointestinal Endoscopy (ASGE). He is also
founding president of the Association for Healthcare Social Media
(AHSM). Dr. Chiang was named Healio Gastroenterology's Disruptive
Innovator of the Year in 2018 and was a Philadelphia Inquirer
Influencer of Healthcare Rookie of the Year in 2019. This year, Dr.
Chiang was a nominee for the GLAAD Media TikTok Advocate of the
Year award.
Dr. Chiang completed his undergraduate degree in Biology at
Duke University, and he earned his
Medical Doctorate from Columbia
University before completing his internal medicine residency
at New York Presbyterian Hospital (Columbia
University). He completed his gastroenterology and bariatric
endoscopy fellowships at Brigham and Women's Hospital/Harvard Medical School and advanced endoscopy
fellowship at Thomas Jefferson
University Hospital. He is also a graduate of the Harvard
T.H. Chan School of Public Health where he earned his master's
degree in Public Health.
About Medtronic
Bold thinking. Bolder actions. We are
Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global
healthcare technology company that boldly attacks the most
challenging health problems facing humanity by searching out and
finding solutions. Our Mission — to
alleviate pain, restore health, and extend life — unites a global
team of 90,000+ passionate people across 150 countries. Our
technologies and therapies treat 70 health conditions and include
cardiac devices, surgical robotics, insulin pumps, surgical tools,
patient monitoring systems, and more. Powered by our diverse
knowledge, insatiable curiosity, and desire to help all those who
need it, we deliver innovative technologies that transform the
lives of two people every second, every hour, every day. Expect
more from us as we empower insight-driven care, experiences that
put people first, and better outcomes for all. In everything we do,
we are engineering the extraordinary. For more information on
Medtronic (NYSE:MDT), visit www.Medtronic.com and follow @Medtronic
on Twitter and LinkedIn.
Any forward-looking statements are subject to risks and
uncertainties such as those described in Medtronic's periodic
reports on file with the Securities and Exchange Commission. Actual
results may differ materially from anticipated results.
Contacts:
|
|
|
|
Sabrina
Zimring
|
Ryan
Weispfenning
|
Public
Relations
|
Investor
Relations
|
+1-720-774-3454
|
+1-763-505-4626
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/austin-l-chiang-md-mph-joins-medtronic-as-chief-medical-officer-for-gastrointestinal-business-301405157.html
SOURCE Medtronic plc